Global Digital Therapeutics Market Size, Share and Demand

The global digital therapeutics market size was valued at USD 5.53 billion in 2022. The market is projected to grow from USD 6.77 billion in 2023 to USD 28.66 billion by 2030, exhibiting a CAGR of 22.9% during the forecast period. 

Software and hardware that digitally retain evidence-based therapeutic procedures for the treatment and management of diseases are referred to as “digital therapeutics” (DTx). The tools and software help address several conditions connected to diabetes, cardiovascular disease, respiratory illnesses, and mental health. The increased prevalence of chronic conditions like diabetes, mental illness, cancer, and heart failure (HF) worldwide is another factor contributing to the increased demand for these items. As a result, patients are increasingly using medicines to manage and treat a variety of chronic conditions. The rising demand for these items among the medical community and the pharmaceutical industry is also projected to fuel market expansion. Fortune Business Insights presents this information in their report titled "Global Digital Therapeutics Market, 2023–2030."

COVID-19 Impact:

Growing Adoption of Digital Therapeutics during COVID-19 Impacted Market Positively

During the anticipated period, COVID-19 will have a favourable effect on the expansion of the global market for digital therapeutics. The need for effective diagnosis and treatment at home has substantially increased throughout the world as a result of the COVID-19 pandemic outbreak and lockdown regulations. The market’s top players' initiatives to manage patients during the COVID-19 pandemic also had a significant impact on the increased use of these medicines. For instance, Fitbit Health Solutions announced a partnership with Stanford Medicine and The Scripps Research Institute in April 2020 to research the use of wearable technology in the identification, monitoring, and treatment of COVID-19 infection in patients.

Segments:

Growing Adoption of Health Monitoring Apps to Propel Market Growth

Based on type, the market is segmented into devices and, software & services.

Due to the rising adoption of software, software and services held the largest market share in 2022. Patients who use the software can easily access their specific meds and conveniently use them. The growing attention given by industry players to the creation of software for people with chronic illnesses like diabetes, heart disease, and mental health will aid in the expansion of this market sector.

 

Comments

Post a Comment

Popular posts from this blog

Autoinjectors Industry Size 2024-2030

  The global " Autoinjectors Market Size 2024 ” Forecast to 2030 research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The Autoinjectors Market report also examines the current state of the industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data. Get a sample PDF of the report at -  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/108507 The global autoinjectors market size was USD 102.51 billion in 2022. The market is projected to grow from USD 111.16 billion in 2023 to USD 233.69 billion by 2030, exhibiting a CAGR of 11.2% during the forecast period. Autoinjectors Market Competitive Analysis: The Autoinjectors Market report examines competitive sc...
Read more

Veterinary Diagnostics Market Growth in United States

  The global veterinary diagnostics market size is projected to reach USD 9.5 billion by 2026, exhibiting a CAGR of 10.0% during the forecast period. Rising prevalence of zoonotic diseases such as swine flu and rabies is the main factor driving the growth of this market. Zoonotic diseases are those which humans contract from animals, birds or insects. They pose grave danger not only to the person infected, but also to other people who might come in close contact with him or her, laying the groundwork for an epidemic. A study published by the Centers for Disease Control and Prevention (CDC) states that 75% of emerging infectious diseases affecting humans are zoonotic in origin. This was already witnessed during the recent Ebola outbreak and rapid spread of swine flu a few years earlier. Preventing the birth of such diseases is crucial for public health as they also cause huge economic losses. According to the WHO, zoonotic epidemics between 1997 and 2009 led to a loss of about USD 8...
Read more

Inflammatory Bowel Disease Treatment Industry Is Booming Worldwide by 2030

 The " Inflammatory Bowel Disease Treatment Market  Size 2024” forecasted to 2030 research provides accurate economic, global, and country-level predictions and analyses. It offers a comprehensive perspective on the competitive market landscape, along with an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. Additionally, the Inflammatory Bowel Disease Treatment Market report examines the current state of the industry, predicted future growth, technological advancements, investment prospects, market economics, and financial data. Competitive Analysis: The Inflammatory Bowel Disease Treatment Market report scrutinizes the competitive scenario by analyzing key players in the market. It includes company profiling of leading market players with Porter's five forces analysis and Value Chain analysis. Furthermore, the report discusses strategies employed by companies for expanding their business through mergers, acquisitions, and...
Read more